| Date | Subject |
| 01/27/2010 06:22:27 PM | |
| On-Pump CABG Should Be Avoided in Patients With Liver Cirrhosis: Presented at STS |
| 01/27/2010 02:44:41 PM | |
| Transient Elastography Accurate for Excluding Advanced Fibrosis in NAFLD |
| 01/05/2010 11:15:53 AM | |
| Liver Stiffness Measurements Identify Patients With Rapid or Slow Fibrosis |
| 01/04/2010 03:42:08 PM | |
| Head-to-Head Studies Identify Best Treatment Regimen for Hepatitis C |
| 12/10/2009 05:51:38 PM | |
| Low-Molecular-Weight Heparin Reduces Risk of Venous Clots in Patients With Pancreatic Cancer: Presented at ASH |
| 12/03/2009 04:10:39 PM | |
| Changes Not Affecting Tumour Size May Better Predict Outcomes to Bevacizumab: Presented at RSNA |
| 12/01/2009 10:40:48 AM | |
| Criteria Based on CT Image of Change in Tumour After Chemotherapy May Help Predict Overall Survival |
| 11/26/2009 11:03:19 AM | |
| Antiviral Therapy to Treat Hepatitis C Declining In the United States |
| 11/25/2009 02:58:39 PM | |
| Liver Transplant Outcomes Similar for Patients With Nonalcoholic vs Alcoholic Cirrhosis |
| 11/24/2009 02:04:19 PM | |
| Adding Cetuximab to Chemotherapy Increases Tumour Shrinkage In Advanced Colorectal Cancer |
| 11/20/2009 02:07:27 PM | |
| New Drug Regimen Shows Promising Results for Advanced Biliary-Tract Cancers |
| 11/20/2009 12:00:01 PM | |
| Chemoembolisation Improves Survival in Patients With Unresectable Liver Cancer |
| 11/10/2009 12:27:03 PM | |
| Four Immunocytochemical Markers Better Distinguish Liver Cancer From Liver Metastases Than Cytomorphology Alone: Presented at ASCP |
| 11/05/2009 12:13:52 PM | |
| Choice of Calcineurin Inhibitor Does Not Influence Outcome of Liver Transplantation in HCV-Positive Recipients: Presented at AASLD |
| 11/04/2009 12:16:22 PM | |
| What Is the Optimal Timing of Hepatitis C Antiviral Therapy Before and After Liver Transplantation? Presented at AASLD |
| 11/03/2009 06:03:16 PM | |
| Extending PEG-IFN Alfa-2a Therapy in Patients With Chronic HBV Can Lead to HBeAg Seroconversion, HBsAg Clearance: Presented at AASLD |
| 11/03/2009 12:26:24 PM | |
| Satavaptan Shows Poor Survival, Despite Modest Effectiveness in the Management of Recurrent Ascites: Presented at AASLD |
| 11/02/2009 07:03:25 PM | |
| Patients Previously Treated With Adefovir Can Achieve Complete Viral Suppression When Switched to Entecavir: Presented at AASLD |
| 11/02/2009 04:12:47 PM | |
| Lamivudine, Entecavir Both Improved Prognosis in Hepatitis B-Related Acute-on-Chronic Liver Failure: Presented at AASLD |
| 11/02/2009 04:05:42 PM | |
| Adefovir Plus Lamivudine Is Effective in Patients With Lamivudine-Resistance Chronic Hepatitis B: Presented at AASLD |
| 11/02/2009 02:52:52 PM | |
| Viral Load Predicts Outcome of Liver Transplant Recipients With Hepatitis C: Presented at AASLD |
| 11/02/2009 01:53:17 PM | |
| Telbivudine Safe and Effective in Suppressing Hepatitis B Over Very Long Term: Presented at AASLD |
| 11/02/2009 12:07:50 PM | |
| Alcohol Does Not Appear to Increase Acetaminophen-Related Acute Liver Failure: Presented at AASLD |
| 11/02/2009 12:01:24 PM | |
| Rifaximin Protects Patients With Cirrhosis From Breakthrough Hepatic Encephalopathy Over Long Term: Presented at AASLD |
| 11/02/2009 11:55:49 AM | |
| Hepatitis B Immune Globulin Therapy May Improve Graft and Patient Survival After Liver Transplantation: Presented at AASLD |
| 11/01/2009 01:40:42 PM | |
| Post-transplant Prophylactic Antiviral Treatment Does Not Prevent Recurrent Hepatitis C: Presented at AASLD |
| 10/30/2009 01:30:27 PM | |
| Patients With Hepatic Encephalopathy Remain in Remission With Rifaximin: Presented at ACG |
| 10/29/2009 02:22:44 PM | |
| Left Side Grafting Has Lower Risk Than Right Lobe in Living Donor Liver Transplantation |
| 09/28/2009 02:16:19 PM | |
| Accelerated Radiotherapy After Neoadjuvant Chemotherapy Shows Promise for Locally Advanced NSCLC: Presented at ECCO-ESMO |
| 09/24/2009 05:42:45 PM | |
| Cisplatin Plus Gemcitabine Provides Significant Survival Benefit Over Gemcitabine Alone in Metastatic Biliary Tract Cancer: Presented at ECCO-ESMO |
| 09/14/2009 04:08:16 PM | |
| Reinfection Common Following Curative Hepatitis C Virus Treatment Among Canadian Prisoners: Presented at ICAAC |
| 09/08/2009 03:45:22 PM | |
| Genetic Variation Increases Risk of Liver Disease in Patients With Cystic Fibrosis |
| 09/03/2009 04:05:23 PM | |
| Sexual Dysfunction Appears to Be a Complication of Hepatitis C Therapy in Men |
| 08/28/2009 02:51:39 PM | |
| High-Dose Ursodeoxycholic Acid Not Effective for Primary Sclerosing Cholangitis |
| 08/24/2009 06:15:33 PM | |
| FDA Investigates Reports of Liver Damage From Weight Loss Drugs |
| 08/19/2009 03:38:25 PM | |
| High Doses of Ursodeoxycholic Acid Leads to Poorer Outcomes in Primary Sclerosing Cholangitis |
| 08/19/2009 03:22:22 PM | |
| Carvedilol Appears Effective in Preventing Variceal Bleeding in Cirrhotic Patients |
| 07/15/2009 01:11:25 PM | |
| Focusing HIV Treatment Helps Control Concurrent Hepatitis B Infection |
| 07/02/2009 03:26:14 PM | |
| FDA Panel Recommends Withdrawal of Acetaminophen-Containing Narcotics |
| 07/02/2009 03:23:32 PM | |
| 90Y Radioembolisation Provides Benefit for Patients With Colorectal Cancer Liver Metastases Who Have Failed Chemotherapy: Presented at ESMO-GI |
| 07/01/2009 05:26:13 PM | |
| Exercise, Independent of Weight Loss, Improves Metabolic Indices in Non-Alcoholic Liver Disease |
| 07/01/2009 05:08:00 PM | |
| Study Examines Liver Transplantation After Drug Induced Acute Liver Failure |
| 07/01/2009 03:50:52 PM | |
| Combined Systemic Chemotherapy, Hepatic Intra-Arterial Drug-Eluting Beads Effective for Unresectable Hepatic Malignancies: Presented at ESMO-GI |
| 07/01/2009 02:55:32 PM | |
| FDG-PET Can Help Prevent Unnecessary Surgery in Patients With Colorectal Liver Metastases: Presented at ESMO-GI |
| 07/01/2009 11:48:53 AM | |
| Radiofrequency Ablation With Chemotherapy Improves Progression-Free Survival in Unresectable Colorectal Cancer Liver Metastases: Presented at ESMO-GI |
| 06/26/2009 06:57:13 PM | |
| Adding Cetuximab to Standard Chemotherapy Improves Response Rates in Patients With Nonresectable Colorectal Liver Metastases: Presented at ESMO-GI |
| 06/23/2009 01:51:11 PM | |
| HBeAg-Positive Pregnant Women With HBV DNA Warrant Further Assessment to Prevent Transmission to Infant: Presented at ICC |
| 06/22/2009 03:35:49 PM | |
| Testosterone Therapy Improves Metabolic Syndrome, Liver Steatosis in Hypogonadal Men: Presented at ENDO 09 |
| 06/11/2009 11:36:57 AM | |
| FDA: Increased Mortality in Stable Liver Transplant Recipients Taking Sirolimus |
| 06/04/2009 05:59:54 PM | |
| Long-Term Once-Daily Tacrolimus Monotherapy Safe, Effective for Liver Transplant Recipients: Presented at ATC |
| 06/03/2009 04:44:54 PM | |
| Gemcitabine Plus Cisplatin Reduces Risks of Death and Progression in Biliary-Tract Cancer: Presented at ASCO |
| 06/03/2009 03:30:00 PM | |
| FDA: Propylthiouracil Increases Risk of Serious Liver Injury, Death |
| 05/29/2009 08:03:53 AM | |
| Some Donor Factors Affect Outcomes for HCV-Positive Liver Transplant Recipients |
| 05/28/2009 04:54:12 PM | |
| Intestinal Bacteria Associated With Nonalcoholic Fatty Liver Disease |
| 05/28/2009 04:52:07 PM | |
| Consensus Interferon Plus Ribavirin Appears Effective for Chronic Hepatitis C |
| 05/20/2009 08:01:50 AM | |
| Sorafenib Approved in Japan for the Treatment of Advanced Liver Cancer |
| 05/15/2009 02:33:30 PM | |
| Coadministration of Quadrivalent HPV Vaccine and Hepatitis A/B Vaccine in Girls Safe, Well Tolerated: Presented at IPV |
| 05/05/2009 05:41:04 PM | |
| Statins May Have Protective Effects in Patients With Diabetes |
| 05/04/2009 04:54:08 PM | |
| Acute Kidney Injury After Liver Transplant Associated With Reduced Patient, Graft Survival |
| 05/04/2009 04:39:24 PM | |
| Hypothyroidism in Women Associated With Liver Cancer |
| 04/30/2009 05:04:46 PM | |
| Satavaptan Reduces Ascites, Need for Paracentesis and Improves Renal Function in Patients With Advanced Cirrhosis: Presented at EASL |
| 04/30/2009 10:48:02 AM | |
| Albinterferon Alfa-2b Comparable to Pegylated Interferon Alfa-2b in Treating Chronic HCV: Presented at EASL |
| 04/29/2009 08:58:41 PM | |
| Adding Telaprevir to Standard Therapy Improves Response, Halves Duration of HCV Treatment |
| 04/29/2009 04:17:15 PM | |
| Sorafenib Increases Overall Survival in Asian Patients With Liver Cancer and Lung, Lymph Node Metastasis: Presented at EASL |
| 04/29/2009 03:29:39 PM | |
| Drug-Eluting Beads Significantly Reduce Doxorubicin Toxicity in Patients With HCC: Presented at EASL |
| 04/28/2009 02:44:13 PM | |
| Severe Adverse Events With Sirolimus More Frequent Than Past Studies Suggest: Presented at EASL |
| 04/27/2009 02:21:37 PM | |
| Similar Survival Rates Among HIV-Positive, HIV-Negative Patients Following Liver Transplant |
| 04/25/2009 04:51:21 PM | |
| Adding Octreotide to Sorafenib May Benefit Patients With Advanced Hepatic Cell Carcinoma Who Have Failed Other Therapies: Presented at EASL |
| 04/25/2009 04:47:42 PM | |
| Boceprevir Plus Interferon/Ribavirin Provides Sustained Viral Response, Lower Relapse Rate in Treatment-Naïve Patients: Presented at EASL |
| 04/25/2009 04:44:54 PM | |
| Corticosteroid Improves Survival Rates in Patients With Severe Alcoholic Hepatitis: Presented at EASL |
| 04/25/2009 04:40:16 PM | |
| HAART Is Well Tolerated, Leads to Rapid Suppression of HBV Replication in HBV-HIV Coinfected Patients: Presented at EASL |
| 04/25/2009 02:28:13 PM | |
| Switching Patients From Twice-Daily to Daily Tacrolimus Appears Safe, Effective in Stable Liver Transplant Recipients: Presented at EASL |
| 04/25/2009 12:52:22 PM | |
| Rifaximin Effectively Reduces Incidence of Breakthrough Hepatic Encephalopathy: Presented at EASL |
| 04/24/2009 05:53:37 PM | |
| Subgroup Analysis Confirms Efficacy, Safety of Sorafenib in Patients With Late-Stage Liver Cancer: Presented at EASL |
| 04/23/2009 04:30:05 PM | |
| Hepatitis B Injection Approved for Treating Acute Exposure |
| 04/07/2009 04:32:13 PM | |
| HIV-Positive Patients Show Lower Response to Hepatitis B Vaccination Even at Double Doses: Presented at BHIVA |
| 04/02/2009 01:48:33 PM | |
| Natural Killer Cells May Explain HCV Recurrence After Liver Transplant |
| 03/27/2009 11:27:05 AM | |
| Molecular Adsorbent Recirculating System Improves Transplant-Free Survival in Patients With Liver Failure: Presented at ISICEM |
| 03/23/2009 01:56:04 PM | |
| Daily Drinking is Biggest Risk Factor in Serious Liver Disease, Researchers Say |
| 03/20/2009 02:52:35 PM | |
| Viral Response in Chronic HCV Can Be Predicted Within 2 Days of Peginterferon Therapy |
| 03/16/2009 04:46:23 PM | |
| Hepatitis B Testing Urged for Non-Hodgkin's Lymphoma Treatment: Presented at NCCN |
| 03/11/2009 05:53:55 PM | |
| FDA Approves Peginterferon/Ribavirin Combo for Treatment-Experienced Patients |
| 03/10/2009 12:07:17 PM | |
| Long-Duration Presurgical Chemotherapy Correlates With Higher Risk of Liver Toxicity for Patients With Colorectal Liver Metastasis: Presented at SSO |
| 03/09/2009 09:57:50 AM | |
| Laparoscopic Management of Liver Cancer Is Feasible in Cirrhotic Patients: Presented at SSO |
| 02/25/2009 02:40:47 PM | |
| Liver Tumours Associated With Metabolic Syndrome Differ From Other Tumours |
| 02/18/2009 03:08:13 PM | |
| Liver Cancer Incidence Has Tripled in the United States, but Survival Rates Are Improving |
| 02/04/2009 02:43:09 PM | |
| Blocking Splenic Artery Helps Liver Transplant Patients With Small-for-Size Syndrome |
| 02/04/2009 01:07:36 PM | |
| Protein Predicts Hepatocellular Carcinoma Recurrence After Transplantation |
| 02/04/2009 11:02:33 AM | |
| Radiofrequency Treatment Better Than Ethanol Injection for Small Liver Tumours |
| 01/20/2009 01:05:40 PM | |
| Low-Carbohydrate Diet Burns More Excess Liver Fat Than Low-Calorie Diet |
| 01/19/2009 04:10:08 PM | |
| Cetuximab Addition Well Tolerated, Allows Patients With Nonresectable Colorectal Liver Metastases to Undergo Surgery: Presented at ASCO-GI |
| 01/19/2009 03:16:56 PM | |
| Asians Frequently Require Sorafenib Dose Reductions for Treatment of Liver Cancer: Presented at ASCO-GI |
| 01/14/2009 04:29:05 PM | |
| Donor Graft Steatosis Associated With Worse Prognosis in Patients With HCV |
| 01/14/2009 12:17:44 PM | |
| Hepatitis C May Increase Pancreatic Cancer Risk |
| 01/14/2009 12:15:57 PM | |
| Orlistat Does Not Appear to Benefit Patients With Fatty Liver Disease |
| 12/31/2008 10:55:24 AM | |
| FDA Approves First Nucleic Acid Test to Screen for Additional Types of HIV in Donated Blood, Tissue |
| 12/17/2008 04:48:37 PM | |
| Erlotinib Linked to Deaths in Patients With Hepatic Impairment, Advanced Solid Tumours |
| 12/17/2008 02:30:17 PM | |
| Sorafenib Appears Effective in Asian-Pacific Patients With Hepatocellular Carcinoma |
| 12/12/2008 01:17:53 PM | |
| FDA Approves PEG-IFN Alfa-2b/Ribavirin Combination Therapy for Paediatric HCV |
| 12/05/2008 01:20:52 PM | |
| Chemoembolisation Effective for Inoperable Liver Cancer, With Minimal Toxicity: Presented at RSNA |
| 12/04/2008 05:10:39 PM | |
